NL-OMON37701
已完成
2 期
Characterisation of ovulation inhibition and effects on metabolic parameters and haemostatic system of multiple administrations of a fixed-dose combination product containing 0.02 mg ethinylestradiol and 2 mg dienogest (24+4) in a multiple administration, comparative parallel-group trial vs. a marketed product containing 0.02 mg ethinylestradiol and 0.10 mg levonorgestrel with healthy females of childbearing potential - Ovulation inhibition study
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- inhibition of ovulation
- 发起方
- Zentiva k.s.
- 入组人数
- 60
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Healhy female subjects aged 18\-35
排除标准
- •Clinically significant abnormalities at screening
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Characterisation of ovulation inhibition and effects on parameters of the human body of multiple doses of a fixed-dose combination product containing 0.02 mg ethinylestradiol and 2 mg dienogest (hormons) in comparison to a marketed product containing 0.02 mg ethinylestradiol and 0.10 mg levonorgestrel in healthy females of childbearing potentialEUCTR2012-000041-12-NLZentiva k.s. Prague
进行中（未招募）
1 期
Characterization of ovulation inhibition of a new vaginal ring (EVE 112, Evestra/Germany) containing the hormones etonogestrel and ethinylestradiol – an open label, single centre, comparative, parallel-group study in healthy females of childbearing potentialEUCTR2016-000115-32-DEEvestra GmbH
进行中（未招募）
1 期
Characterization of ovulation inhibition of a new vaginal ring containing the hormone trimegestone - an open-label, single-centre study in healthy females of childbearing potentialInvestigation of ovulation inhibition for indication of contraceptionTherapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]EUCTR2017-004664-36-DEEvestra GmbH100
已完成
2 期
Evaluation of Pharmacodynamic Effects on Ovulation and Cycle ControlOvulation SuppressionNCT01250210Agile Therapeutics123
尚未招募
1 期
A study to observe the effect of Pushpadhanva Rasa on rupture of ovum from ovaries.Health Condition 1: null- Female patients with primary or secondary infertility due to Anovulation.Health Condition 2: E288- Other ovarian dysfunctionCTRI/2018/10/016231Parul Institute of Ayurveda